Multiparametric 0.4-T low-field MRI mapping for metabolic dysfunction-associated steatotic liver disease in rats

Abstract Objective Low-field MRI may broaden access to quantitative liver imaging, but low signal-to-noise ratio and coexisting steatosis, inflammation, fibrosis, and iron complicate relaxometry in metabolic dysfunction-associated steatotic liver disease (MASLD). We evaluated multiparametric 0.4-T MRI with deep-learning-reconstructed T1 mapping in rats. Materials and methods In this prospective cross-sectional preclinical study, 90 male Wistar rats underwent 0.4-T liver MRI during dietary induction, progression, and recovery. Metrics included native T1, fat-corrected T1 (FcT1), T2, T2 * , and an apparent proton density fat fraction (PDFF) estimate. Whole-section digital pathology quantified steatosis, fibrosis, inflammation, and iron. Associations were assessed using iron-adjusted and stage-aware analyses, multivariable regression with variance inflation factors, and receiver operating characteristic analysis. Results Steatosis strongly correlated with T2 (ρ = 0.90, p < 0.001) and PDFF (ρ = 0.88, p < 0.001). For high inflammation, T2 and T2 * yielded areas under the curve (AUROCs) of 0.86 (95% confidence interval 0.78–0.94) and 0.80 (0.71–0.89), respectively ( p = 0.294); specificities were 82.2% and 91.1%, respectively. For fibrosis, native T1 yielded higher AUROCs than FcT1 at collagen proportionate area (CPA) > 2.42% (0.77 versus 0.62; p = 0.008) and > 2.90% (0.78 versus 0.60; p = 0.001). Stage-aware analyses attenuated T1–fibrosis associations, and recovery animals showed residual fibrosis with near-baseline T1. Conclusion Multiparametric 0.4-T MRI showed complementary, partly stage-dependent associations with MASLD pathology. T2/PDFF tracked steatosis; T2 * retained an inflammation-related association after stage adjustment; and T1 elevation characterized active high-burden progression rather than isolated residual fibrosis. Human validation and platform calibration are required. Key Points Question Noninvasive MASLD assessment needs accessible imaging biomarkers that account for coexisting steatosis, inflammation, fibrosis, and iron-related confounding in liver MRI. Findings Multiparametric 0.4-T MRI showed complementary but stage-dependent associations: T2/apparent PDFF tracked steatosis, T2 * related to inflammation, and T1 rose during high-burden progression. Relevance statement Multiparametric 0.4-T MRI provides complementary pathology-correlated measurements for MASLD assessment in rats, but reconstruction-dependent T1 bias and apparent PDFF estimation require platform calibration and human validation before clinical interpretation.

Authors

Publication Details

Journal
European Radiology Experimental
Published
2026-11-14
DOI
https://doi.org/10.1186/s41747-026-00852-6
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multiparametric 0.4-T low-field MRI mapping for metabolic dysfunction-associated steatotic liver disease in rats

Azusa Kitao, Satoshi Kobayashi, Kazuto Kozaka, Hibiki YAMAUCHI et al.
European Radiology Experimental
Liver Disease Diagnosis and Treatment
article

Multiparametric 0.4-T low-field MRI mapping for metabolic dysfunction-associated steatotic liver disease in rats

Azusa Kitao, Satoshi Kobayashi, Kazuto Kozaka, Hibiki YAMAUCHI, Toshinari Takamura, Kenichiro Okumura, Taro Yamashita, Kenichi Harada, Yumie Takeshita, Naoki Ohno
article en

Abstract

Abstract Objective Low-field MRI may broaden access to quantitative liver imaging, but low signal-to-noise ratio and coexisting steatosis, inflammation, fibrosis, and iron complicate relaxometry in metabolic dysfunction-associated steatotic liver disease (MASLD). We evaluated multiparametric 0.4-T MRI with deep-learning-reconstructed T1 mapping in rats. Materials and methods In this prospective cross-sectional preclinical study, 90 male Wistar rats underwent 0.4-T liver MRI during dietary induction, progression, and recovery. Metrics included native T1, fat-corrected T1 (FcT1), T2, T2 * , and an apparent proton density fat fraction (PDFF) estimate. Whole-section digital pathology quantified steatosis, fibrosis, inflammation, and iron. Associations were assessed using iron-adjusted and stage-aware analyses, multivariable regression with variance inflation factors, and receiver operating characteristic analysis. Results Steatosis strongly correlated with T2 (ρ = 0.90, p < 0.001) and PDFF (ρ = 0.88, p < 0.001). For high inflammation, T2 and T2 * yielded areas under the curve (AUROCs) of 0.86 (95% confidence interval 0.78–0.94) and 0.80 (0.71–0.89), respectively ( p = 0.294); specificities were 82.2% and 91.1%, respectively. For fibrosis, native T1 yielded higher AUROCs than FcT1 at collagen proportionate area (CPA) > 2.42% (0.77 versus 0.62; p = 0.008) and > 2.90% (0.78 versus 0.60; p = 0.001). Stage-aware analyses attenuated T1–fibrosis associations, and recovery animals showed residual fibrosis with near-baseline T1. Conclusion Multiparametric 0.4-T MRI showed complementary, partly stage-dependent associations with MASLD pathology. T2/PDFF tracked steatosis; T2 * retained an inflammation-related association after stage adjustment; and T1 elevation characterized active high-burden progression rather than isolated residual fibrosis. Human validation and platform calibration are required. Key Points Question Noninvasive MASLD assessment needs accessible imaging biomarkers that account for coexisting steatosis, inflammation, fibrosis, and iron-related confounding in liver MRI. Findings Multiparametric 0.4-T MRI showed complementary but stage-dependent associations: T2/apparent PDFF tracked steatosis, T2 * related to inflammation, and T1 rose during high-burden progression. Relevance statement Multiparametric 0.4-T MRI provides complementary pathology-correlated measurements for MASLD assessment in rats, but reconstruction-dependent T1 bias and apparent PDFF estimation require platform calibration and human validation before clinical interpretation.

European Radiology ExperimentalVol. 10(1)
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon